Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 years.

Paidpally V, Tahari AK, Lam S, Alluri K, Marur S, Koch W, Wahl RL, Subramaniam RM.

J Nucl Med. 2013 Dec;54(12):2039-45. doi: 10.2967/jnumed.113.121285. Epub 2013 Oct 7.

2.

Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.

Antoniou AJ, Marcus C, Tahari AK, Wahl RL, Subramaniam RM.

J Nucl Med. 2014 Jul;55(7):1062-8. doi: 10.2967/jnumed.113.136770. Epub 2014 Apr 28.

3.

Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival.

Marcus C, Antoniou A, Rahmim A, Ladenson P, Subramaniam RM.

J Med Imaging Radiat Oncol. 2015 Jun;59(3):281-8. doi: 10.1111/1754-9485.12286. Epub 2015 Feb 11.

PMID:
25676871
4.

Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.

Marcus C, Ciarallo A, Tahari AK, Mena E, Koch W, Wahl RL, Kiess AP, Kang H, Subramaniam RM.

J Nucl Med. 2014 Sep;55(9):1411-6. doi: 10.2967/jnumed.113.136796. Epub 2014 Jun 19.

5.

¹⁸F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.

Marcus C, Marashdeh W, Ahn SJ, Taghipour M, Subramaniam RM.

J Nucl Med. 2015 Jul;56(7):989-94. doi: 10.2967/jnumed.115.156240. Epub 2015 May 7.

6.

FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy.

Taghipour M, Sheikhbahaei S, Wray R, Agrawal N, Richmon J, Kang H, Subramaniam RM.

AJR Am J Roentgenol. 2016 May;206(5):1093-100. doi: 10.2214/AJR.15.15604. Epub 2016 Mar 21.

PMID:
26999264
7.

18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.

Sheikhbahaei S, Mena E, Marcus C, Wray R, Taghipour M, Subramaniam RM.

J Nucl Med. 2016 Jun;57(6):855-60. doi: 10.2967/jnumed.115.165480. Epub 2016 Feb 2.

8.

FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.

Paidpally V, Chirindel A, Chung CH, Richmon J, Koch W, Quon H, Subramaniam RM.

AJR Am J Roentgenol. 2014 Aug;203(2):W139-45. doi: 10.2214/AJR.13.11654.

9.

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY.

J Nucl Med. 2009 Jan;50(1):24-9. doi: 10.2967/jnumed.108.055806. Epub 2008 Dec 17.

10.

18F-FDG PET/CT and lung cancer: value of fourth and subsequent posttherapy follow-up scans for patient management.

Marcus C, Paidpally V, Antoniou A, Zaheer A, Wahl RL, Subramaniam RM.

J Nucl Med. 2015 Feb;56(2):204-8. doi: 10.2967/jnumed.114.147884. Epub 2015 Jan 22.

11.

Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma.

Abgral R, Le Roux PY, Rousset J, Querellou S, Valette G, Nowak E, Turzo A, Tissot V, Marianowski R, Salaün PY.

Nucl Med Commun. 2013 Jun;34(6):551-6. doi: 10.1097/MNM.0b013e32836089ab.

PMID:
23587836
12.

18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.

Mena E, Taghipour M, Sheikhbahaei S, Mirpour S, Xiao J, Subramaniam RM.

Clin Nucl Med. 2016 Sep;41(9):e403-9. doi: 10.1097/RLU.0000000000001275.

PMID:
27355846
13.

First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.

Burger IA, Zitzmann-Kolbe S, Pruim J, Friebe M, Graham K, Stephens A, Dinkelborg L, Kowal K, Schibli R, Luurtsema G, Maas B, Horn-Tutic M, Haerle SK, Wiegers J, Schaefer NG, Hany TF, von Schulthess GK.

J Nucl Med. 2014 Nov;55(11):1778-85. doi: 10.2967/jnumed.114.140699. Epub 2014 Sep 25.

14.

Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.

Ong SC, Schöder H, Lee NY, Patel SG, Carlson D, Fury M, Pfister DG, Shah JP, Larson SM, Kraus DH.

J Nucl Med. 2008 Apr;49(4):532-40. doi: 10.2967/jnumed.107.044792. Epub 2008 Mar 14.

15.

The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.

Zhang I, Branstetter BF 4th, Beswick DM, Maxwell JH, Gooding WE, Ferris RL.

Arch Otolaryngol Head Neck Surg. 2011 Nov;137(11):1106-11. doi: 10.1001/archoto.2011.181.

PMID:
22106234
16.

(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.

Kim JW, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.

Br J Cancer. 2013 Dec 10;109(12):2973-9. doi: 10.1038/bjc.2013.668. Epub 2013 Oct 22.

17.

Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.

Khong PL, Huang B, Lee EY, Chan WK, Kwong YL.

J Nucl Med. 2014 Jun;55(6):911-6. doi: 10.2967/jnumed.113.131946. Epub 2014 May 12.

18.

18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.

Singnurkar A, Solomon SB, Gönen M, Larson SM, Schöder H.

J Nucl Med. 2010 Dec;51(12):1833-40. doi: 10.2967/jnumed.110.076778. Epub 2010 Nov 15. Erratum in: J Nucl Med. 2011 Jan;52(1):106.

19.

Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?

Castaldi P, Rufini V, Bussu F, Miccichè F, Dinapoli N, Autorino R, Lago M, De Corso E, Almadori G, Galli J, Paludetti G, Giordano A, Valentini V.

Radiother Oncol. 2012 Apr;103(1):63-8. doi: 10.1016/j.radonc.2012.03.001. Epub 2012 Mar 27.

PMID:
22459579
20.

Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.

Koyasu S, Nakamoto Y, Kikuchi M, Suzuki K, Hayashida K, Itoh K, Togashi K.

AJR Am J Roentgenol. 2014 Apr;202(4):851-8. doi: 10.2214/AJR.13.11013.

PMID:
24660716

Supplemental Content

Support Center